LONDON, May 16 /PRNewswire/ Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company s oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicag